Evidence map›Paper›PMID 41020174›Full record

ArticleNature synthesis2025

A broadly applicable stereospecific glycosylation.

Qing Zhang, Nils J Flodén, Yongliang Zhang, Jielin Yang, Philip Kohnke, José Danglad-Flores, Eric T Sletten, Peter H Seeberger, Liming Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature synthesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. SOrganic letters · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qing ZhangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA, USA.
Nils J FlodénMax Planck Institute of Colloids and Interfaces, Potsdam, Germany.ORCID 0000-0001-6179-4519
Yongliang ZhangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA, USA.ORCID 0000-0002-6671-2495
Jielin YangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA, USA.
Philip KohnkeDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA, USA.
José Danglad-FloresMax Planck Institute of Colloids and Interfaces, Potsdam, Germany.
Eric T SlettenMax Planck Institute of Colloids and Interfaces, Potsdam, Germany.ORCID 0000-0003-2177-2969
Peter H SeebergerMax Planck Institute of Colloids and Interfaces, Potsdam, Germany.ORCID 0000-0003-3394-8466
Liming ZhangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA, USA.ORCID 0000-0002-5306-1515

Funding

Development of novel approaches for stereoselective construction of glycosidic linkagesU01GM125289 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI ZHANG, LIMING, ZHU, JIANGLONG · 2017 to 2020
$2.5M
Research Supplements to Promote Diversity in Health-Related ResearchR35GM139640 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Liming Zhang · 2021 to 2026
$2.5M
NIGMS NIH HHS R35 GM139640NIGMS NIH HHS U01 GM125289
6 · The paper itself

Abstract

The development of a general strategy for stereospecific construction of every type of glycosidic linkage remains a much sought-after yet unrealized goal. Such a strategy would be particularly useful in the context of complex glycan syntheses. Glycosylations involving an S

Identifiers

PMID41020174
PMCPMC12463317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.